PIII · NASDAQ
P3 Health Partners (PIII) Stock Price & Fundamentals
P3 Health Partners (PIII) closed at $227.74 on Oct 9, 2026, down 0.18% from the previous close of $228.14.
Share price, past year
1Y −15.99%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $227.74 |
| Sep 30, 2026 | $233.45 |
| Aug 31, 2026 | $237.78 |
| Jul 31, 2026 | $248.54 |
| Jun 30, 2026 | $270.28 |
| May 29, 2026 | $269.65 |
| Apr 30, 2026 | $266.61 |
| Mar 31, 2026 | $273.77 |
| Feb 27, 2026 | $276.25 |
| Jan 30, 2026 | $276.36 |
| Dec 31, 2025 | $276.42 |
| Nov 28, 2025 | $282.08 |
| Oct 31, 2025 | $270.76 |
Key statistics
- Market cap
- —
- P/E (TTM)
- —
- EPS (TTM)
- −$33.06
- Revenue (TTM)
- $1.50B
- Net income (TTM)
- −$98.44M
- Shares outstanding
- —
- Dividend yield
- —
- 52-week range
- $225.28 – $288.79
Financials
P3 Health Partners reported revenue of $1.46B for fiscal 2024.
P3 Health Partners reported a net loss of $147.95M in fiscal 2024.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2024ended Dec 31, 2025 | $1.46B | −2.8% | −$147.95M | −10.1% | −$45.26 | — |
| FY2025ended Dec 31, 2024 | $1.50B | +18.5% | −$135.85M | −9.1% | −$54.06 | −$110.13M |
| FY2022ended Dec 31, 2023 | $1.27B | +20.7% | −$57.77M | −4.6% | −$0.63 | −$77.86M |
| FY2021ended Dec 31, 2022 | $1.05B | +113.7% | −$270.13M | −25.7% | −$6.50 | −$128.25M |
| FY2021ended Dec 31, 2020 | $491.06M | +237.5% | −$270.13M | −55.0% | −$6.50 | −$128.25M |
| FY2018ended Dec 31, 2019 | $145.48M | — | −$41.97M | −28.9% | — | −$29.74M |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q2 FY2025ended Jun 30, 2026 | $386.38M | $7.44M | −$0.63 |
| Q1 FY2025ended Mar 31, 2026 | $386.39M | $1.22M | $0.32 |
| Q4 FY2024ended Dec 31, 2025 | $384.81M | −$75.52M | — |
| Q3 FY2024ended Sep 30, 2025 | $345.25M | −$31.59M | −$9.67 |
| Q2 FY2024ended Jun 30, 2025 | $355.79M | −$20.36M | −$6.23 |
| Q1 FY2024ended Mar 31, 2025 | $373.23M | −$20.48M | −$6.28 |
| Q4 FY2025ended Dec 31, 2024 | $370.69M | −$58.62M | −$23.13 |
| Q3 FY2025ended Sep 30, 2024 | $362.12M | −$46.51M | −$15.70 |
Company profile
- Name
- P3 Health Partners Inc.
- Ticker
- PIII
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Services-Health Services
- Headquarters
- 2045 W Grand Ave Ste B, Pmb # 82152, Chicago, IL 60612-1577
- Incorporated in
- DE
- Fiscal year ends
- December
- SEC CIK
- 0001832511
Recent SEC filings
- Sep 11, 2026
- Aug 10, 2026
- Aug 10, 2026
- Jul 6, 2026
- Jun 10, 2026
- May 26, 2026
- May 15, 2026
- May 14, 2026
Frequently asked questions
What is P3 Health Partners's stock price?
P3 Health Partners (PIII) closed at $227.74 on Oct 9, 2026, down 0.18% from the previous close of $228.14.
How much revenue does P3 Health Partners make?
P3 Health Partners reported revenue of $1.46B for fiscal 2024.
Does P3 Health Partners pay a dividend?
P3 Health Partners's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from P3 Health Partners Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures